Sipai Health Technology Co., Ltd. (00314) disclosed that on 6 February 2026, 364,600 ordinary shares were repurchased at prices ranging from HKD 2.29 to HKD 2.38 per share, totaling HKD 863,798. These repurchased shares are held in treasury.

Following the transaction, the number of issued shares (excluding treasury shares) stood at 738,459,514, while the number of treasury shares rose to 27,118,600. The overall share capital of 765,578,114 remained unchanged. The repurchase accounted for approximately 0.049% of the issued shares prior to the repurchase. The company holds a repurchase mandate that authorizes up to 75,022,471 shares, with 12,938,800 shares already repurchased, representing about 1.725% of total issued shares at the time the mandate was granted.

According to the disclosure, a 30-day moratorium on issuing new shares or selling treasury shares now applies until 8 March 2026. The company’s directors confirmed the repurchase complied with relevant exchange requirements, and there were no material changes to previously filed statements.